The Experts below are selected from a list of 11391 Experts worldwide ranked by ideXlab platform

Robert Montes Mico - One of the best experts on this subject based on the ideXlab platform.

  • central vault after phakic intraocular lens implantation correlation with anterior chamber depth white to white distance spherical equivalent and patient age
    Journal of Cataract and Refractive Surgery, 2012
    Co-Authors: Jose F Alfonso, Luis Fernandezvega, Carlos Lisa, Paulo Rodrigues Fernandes, Jorge Jorge, Robert Montes Mico
    Abstract:

    Purpose To compare the central postoperative vault of a phakic intraocular lens (pIOL) to correct myopia, myopic astigmatism, and Hyperopia and identify ocular and lens parameters that might predict the vault amount. Setting Fernandez-Vega Ophthalmological Institute, Oviedo, Spain. Design Cohort study. Methods Three months after implantation of Implantable Collamer Lens pIOLs to correct myopia, Hyperopia, and myopic astigmatism, central vault was measured using optical coherence tomography. Patients were divided into groups according to the preoperative anterior chamber depth (ACD) to compare the effects of ACD, white-to-white (WTW) distance, and lens diameter on postoperative pIOL vault. Results Hyperopic pIOLs had statistically significantly lower vault followed by myopic pIOLs and toric pIOLs, which had a higher mean value and narrower range (260 to 860 μm). Measured vaults had a positive correlation with preoperative ACD (r = .32, P Conclusions Central vaulting was lower in hyperopic eyes. Current nomograms for pIOL diameter selection based on ACD and WTW might yield ideal vault and may have to be adjusted for older patients, shallower ACD, lower WTW, and lower SE. Financial Disclosure No author has a financial or proprietary interest in any material or method mentioned.

  • central vault after phakic intraocular lens implantation correlation with anterior chamber depth white to white distance spherical equivalent and patient age
    Journal of Cataract and Refractive Surgery, 2012
    Co-Authors: Jose F Alfonso, Luis Fernandezvega, Carlos Lisa, Paulo Rodrigues Fernandes, Jorge Jorge, Robert Montes Mico
    Abstract:

    Purpose To compare the central postoperative vault of a phakic intraocular lens (pIOL) to correct myopia, myopic astigmatism, and Hyperopia and identify ocular and lens parameters that might predict the vault amount. Setting Fernandez-Vega Ophthalmological Institute, Oviedo, Spain. Design Cohort study. Methods Three months after implantation of Implantable Collamer Lens pIOLs to correct myopia, Hyperopia, and myopic astigmatism, central vault was measured using optical coherence tomography. Patients were divided into groups according to the preoperative anterior chamber depth (ACD) to compare the effects of ACD, white-to-white (WTW) distance, and lens diameter on postoperative pIOL vault. Results Hyperopic pIOLs had statistically significantly lower vault followed by myopic pIOLs and toric pIOLs, which had a higher mean value and narrower range (260 to 860 μm). Measured vaults had a positive correlation with preoperative ACD ( r = .32, P r = .29, P r = −0.21, P r = −0.12, P =.025). Eyes with a vault of 250 μm or less had a shallower ACD than eyes with a vault between 250 μm and 750 μm (mean difference −0.11 mm; P =.012) and those with a vault greater than 750 μm (mean difference −0.25 mm; P Conclusions Central vaulting was lower in hyperopic eyes. Current nomograms for pIOL diameter selection based on ACD and WTW might yield ideal vault and may have to be adjusted for older patients, shallower ACD, lower WTW, and lower SE. Financial Disclosure No author has a financial or proprietary interest in any material or method mentioned.

Christy Stevens - One of the best experts on this subject based on the ideXlab platform.

  • lasik correction of spherical Hyperopia hyperopic astigmatism and mixed astigmatism with the ladarvision excimer laser system
    Ophthalmology, 2002
    Co-Authors: James J Salz, Christy Stevens
    Abstract:

    Abstract Objective To assess the safety and effectiveness of the LADARVision active tracking narrow beam excimer laser system (Alcon Surgical, Orlando, FL) using laser in situ keratomileusis (LASIK) for correction of spherical Hyperopia, hyperopic astigmatism, and mixed astigmatism. Design A multicenter, prospective non-randomized (self-controlled) comparative trial. Participants A total of 360 eyes, including 152 spherical hyperopic, 143 hyperopic astigmatic, and 65 mixed astigmatic, were treated for up to +6.00-diopter (D) sphere with up to −6.00-D cylinder. Intervention Treatments were performed at six sites in the United States using a 6-mm optic zone with a 1.5-mm peripheral blend zone for a maximum ablation zone diameter of 9 mm. Main outcome measures Uncorrected visual acuity (UCVA), manifest refraction, vector analysis, best spectacle-corrected visual acuity (BSCVA), complications and adverse reactions, subjective symptoms, and patient satisfaction. Results Six and 12 months of follow-up, respectively, were available on 143 and 117 spherical hyperopic eyes, 124 and 74 hyperopic astigmatic eyes, and 57 and 38 mixed astigmatic eyes, respectively. For spherical hyperopes at 6 and 12 months, UCVA was 20/40 or better in 93.4% and 93.9% of eyes, respectively. The manifest refraction spherical equivalent (MRSE) was within 0.50 D of intended in 65.0% and 74.1% of eyes, respectively, and within 1.00 D in 87.4% and 91.4%, respectively. Refractive stability was demonstrated in 94.2% or more of eyes between the intervals of 1 to 3 months and 3 to 6 months and in 95.3% or more of eyes to 12 months. A loss of two lines of BSCVA occurred in 3.5% and 3.4%, respectively, and no eyes lost more than two lines. For hyperopic astigmats at 6 and 12 months, UCVA was 20/40 or better in 90.9% and 93.8% of eyes, respectively. The MRSE was within 0.50 D of intended in 60.5% and 73.0% of eyes, respectively, and within 1.00 D in 88.7% and 89.2% of eyes, respectively. Refractive stability was demonstrated in 96.5% or more of eyes, respectively, between the intervals of 1 to 3 months and 3 to 6 months and 95.5% or more to 12 months. A loss of two lines of BSCVA occurred in 5.8% and 1.4% of eyes, respectively, and no eyes lost more than two lines. For mixed astigmats at 6 and 12 months, UCVA was 20/40 or better in 92.6% and 94.4% of eyes, respectively. The MRSE was within 0.50 D of intended in 64.9% and 73.7% of eyes, respectively, and within 1.00 D in 87.7% and 94.7% of eyes, respectively. Refractive stability was demonstrated in 100% of eyes between the intervals of 1 to 3 months and 3 to 6 months and in 97.0% or more to 12 months. A loss of two lines of BSCVA occurred in 1.9% and 0.0% of eyes, respectively, and no eyes lost more than two lines. Conclusions The data support safety and effectiveness of the LASIK correction of spherical Hyperopia, hyperopic astigmatism, and mixed astigmatism with the LADARVision system.

  • lasik correction of spherical Hyperopia hyperopic astigmatism and mixed astigmatism with the ladarvision excimer laser system
    Ophthalmology, 2002
    Co-Authors: James J Salz, Christy Stevens
    Abstract:

    Abstract Objective To assess the safety and effectiveness of the LADARVision active tracking narrow beam excimer laser system (Alcon Surgical, Orlando, FL) using laser in situ keratomileusis (LASIK) for correction of spherical Hyperopia, hyperopic astigmatism, and mixed astigmatism. Design A multicenter, prospective non-randomized (self-controlled) comparative trial. Participants A total of 360 eyes, including 152 spherical hyperopic, 143 hyperopic astigmatic, and 65 mixed astigmatic, were treated for up to +6.00-diopter (D) sphere with up to −6.00-D cylinder. Intervention Treatments were performed at six sites in the United States using a 6-mm optic zone with a 1.5-mm peripheral blend zone for a maximum ablation zone diameter of 9 mm. Main outcome measures Uncorrected visual acuity (UCVA), manifest refraction, vector analysis, best spectacle-corrected visual acuity (BSCVA), complications and adverse reactions, subjective symptoms, and patient satisfaction. Results Six and 12 months of follow-up, respectively, were available on 143 and 117 spherical hyperopic eyes, 124 and 74 hyperopic astigmatic eyes, and 57 and 38 mixed astigmatic eyes, respectively. For spherical hyperopes at 6 and 12 months, UCVA was 20/40 or better in 93.4% and 93.9% of eyes, respectively. The manifest refraction spherical equivalent (MRSE) was within 0.50 D of intended in 65.0% and 74.1% of eyes, respectively, and within 1.00 D in 87.4% and 91.4%, respectively. Refractive stability was demonstrated in 94.2% or more of eyes between the intervals of 1 to 3 months and 3 to 6 months and in 95.3% or more of eyes to 12 months. A loss of two lines of BSCVA occurred in 3.5% and 3.4%, respectively, and no eyes lost more than two lines. For hyperopic astigmats at 6 and 12 months, UCVA was 20/40 or better in 90.9% and 93.8% of eyes, respectively. The MRSE was within 0.50 D of intended in 60.5% and 73.0% of eyes, respectively, and within 1.00 D in 88.7% and 89.2% of eyes, respectively. Refractive stability was demonstrated in 96.5% or more of eyes, respectively, between the intervals of 1 to 3 months and 3 to 6 months and 95.5% or more to 12 months. A loss of two lines of BSCVA occurred in 5.8% and 1.4% of eyes, respectively, and no eyes lost more than two lines. For mixed astigmats at 6 and 12 months, UCVA was 20/40 or better in 92.6% and 94.4% of eyes, respectively. The MRSE was within 0.50 D of intended in 64.9% and 73.7% of eyes, respectively, and within 1.00 D in 87.7% and 94.7% of eyes, respectively. Refractive stability was demonstrated in 100% of eyes between the intervals of 1 to 3 months and 3 to 6 months and in 97.0% or more to 12 months. A loss of two lines of BSCVA occurred in 1.9% and 0.0% of eyes, respectively, and no eyes lost more than two lines. Conclusions The data support safety and effectiveness of the LASIK correction of spherical Hyperopia, hyperopic astigmatism, and mixed astigmatism with the LADARVision system.

Edward E. Manche - One of the best experts on this subject based on the ideXlab platform.

  • wavefront guided laser in situ keratomileusis retreatment for consecutive Hyperopia and compound hyperopic astigmatism
    Journal of Cataract and Refractive Surgery, 2008
    Co-Authors: Simon R Bababeygy, Christopher I Zoumalan, Fred Y Chien, Edward E. Manche
    Abstract:

    Purpose To evaluate the efficacy, predictability, and safety of wavefront-guided laser in situ keratomileusis (LASIK) using the Visx CustomVue excimer laser (Advanced Medical Optics) in eyes with consecutive Hyperopia and compound hyperopic astigmatism after LASIK. Setting Stanford University School of Medicine, Department of Ophthalmology, Stanford, California, USA. Methods This retrospective analysis included 19 eyes of 16 patients who had wavefront-guided LASIK for consecutive Hyperopia and compound hyperopic astigmatism after initial LASIK surgery. Primary outcome variables, including uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), higher-order aberration (HOA) analysis, and spherical equivalence, were evaluated at 1 and 3 months. Nine eyes of 7 patients were available for all visits. Results The mean patient age was 51.7 years ± 3.77 (SD) (range 44 to 55 years). The mean preoperative manifest refractive spherical equivalent (MRSE) was 0.99 ± 0.32 diopters (D) (range 0.50 to 1.50 D) and the mean 3-month postoperative MRSE, −0.04 ± 0.66 D (range −1.50 to 0.75 D). At 1 month, 57.9% of eyes had a UCVA of 20/20 or better and 78.9% of 20/25 or better; 84.2% were within ±1.00 D of emmetropia. At 3 months, 66.7% of eyes had a UCVA of 20/20 or better and 88.9% of 20/25 or better; 88.9% were within ±1.00 D of emmetropia. No eye lost 2 or more lines of BSCVA at 1 or 3 months. Conclusion Wavefront-guided LASIK was an effective, predictable, and safe procedure for consecutive Hyperopia and compound hyperopic astigmatism after LASIK.

  • comparison of videokeratographic functional optical zones in conductive keratoplasty and laser in situ keratomileusis for Hyperopia
    Journal of Refractive Surgery, 2003
    Co-Authors: Maria C Rojas, Edward E. Manche
    Abstract:

    PURPOSE: To compare the videokeratographic functional optical zone of eyes treated with conductive keratoplasty to eyes treated with laser in situ keratomileusis (LASIK) for Hyperopia. METHODS: Sixteen eyes treated with conductive keratoplasty for Hyperopia were retrospectively evaluated to determine the size of the videokeratographic functional optical zone. The functional optical zone of these eyes was compared to the functional optical zone of 16 eyes that underwent LASIK for Hyperopia with the VISX S2 excimer laser, for comparable amounts of Hyperopia. The functional optical zone was measured at the edge of central corneal steepening and paracentral flattening on videokeratography 3 to 6 months after surgery. RESULTS: The functional optical zone after surgery measured an average of 5.6 mm horizontally and 5.6 mm vertically in the conductive keratoplasty eyes, and 4.7 mm horizontally and 5.1 mm vertically in the hyperopic LASIK eyes (P<.001 and P<.005). The mean functional optical zone area was 31.1 mm 2 in the conductive keratoplasty eyes and 24.6 mm 2 in the hyperopic LASIK eyes (P<.001). The functional optical zone created by conductive keratoplasty had more uniform central steepening and less peripheral blending than the functional optical zone created by hyperopic LASIK. CONCLUSION: Conductive keratoplasty was effective at creating central steepening in the cornea. The functional optical zone resulting from conductive keratoplasty was significantly larger than that obtained with hyperopic LASIK using the VISX S2 excimer laser.

  • Factors influencing the outcome of hyperopic lamellar keratoplasty.
    Journal of Cataract & Refractive Surgery, 1998
    Co-Authors: Gary Ghiselli, Edward E. Manche, Robert K. Maloney
    Abstract:

    Abstract Purpose: To determine which factors affect the refractive outcome of hyperopic lamellar keratoplasty. Setting: Jules Stein Eye Institute and Department of Ophthalmology, UCLA, Los Angeles, California, USA. Methods: This retrospective study comprised 38 consecutive eyes of 25 patients with naturally occurring Hyperopia who had automated lamellar keratoplasty by one surgeon. Mean attempted correction was 3.80 diopters (D) (range of 1.50 to 6.00 D); 34 eyes were followed for 3 months. The effect of applanation lens diameter, keratometry, age, corneal thickness, absolute flap thickness in microns, thickness of the posterior lamellae in microns, and flap thickness as a percentage of corneal thickness were determined using multivariate linear regression. Results: With current nomograms, mean undercorrection 3 months after hyperopic lamellar keratoplasty was 1.26 D ± 0.91 (SD); 14 of 34 eyes were within ± 1.00 D of the attempted correction. The best predictive factors of achieved correction were applanation lens diameter and absolute flap thickness in microns, which accounted for 54% of the variability in outcome. Keratometry, corneal thickness, and flap thickness as a percentage of corneal thickness had no significant additional predictive value. Conclusion: The refractive outcome of hyperopic lamellar keratoplasty was primarily determined by applanation lens diameter and absolute flap thickness in microns. Current nomograms suggest that flap thickness as a percentage of corneal thickness is a major determinant of effect, but this factor appears unimportant to the refractive effect of hyperopic lamellar keratoplasty. We hypothesize that it is slight swelling of the anterior corneal stroma rather than the bulging of the posterior cornea that causes the hyperopic correction in hyperopic lamellar keratoplasty.

  • Lamellar keratoplasty for Hyperopia.
    Journal of refractive surgery (Thorofare N.J. : 1995), 1996
    Co-Authors: Edward E. Manche, Anisha Judge, Robert K. Maloney
    Abstract:

    PURPOSE Lamellar keratoplasty for Hyperopia (automated lamellar keratoplasty for Hyperopia) can correct Hyperopia by weakening the cornea with a deep lamellar resection. The safety and efficacy of the procedure is uncertain. METHODS Twenty-four eyes of 17 patients underwent hyperopic lamellar keratoplasty using the automated corneal shaper (Chiron Corp, Irvine, Calif) by one surgeon using a flap technique. The mean attempted correction was +3.90 +/- 0.90 D (range, +2.00 to +6.00). The eyes were followed for 1 month (23 eyes) to 6 months (17 eyes). RESULTS Six months after hyperopic lamellar keratoplasty, the mean difference between attempted and achieved correction was an undercorrection of +1.40 +/- 0.80 diopters (D) with 7 of 17 eyes within 1.00 D of the attempted correction. No eyes were overcorrected, and 15 eyes were undercorrected. In eyes with a refractive goal of emmetropia, uncorrected visual acuity was 20/40 or better in 13 of 15 eyes and 20/20 or better in 8 of 15 eyes. No eye lost two or more lines of spectacle-corrected visual acuity at 3 or 6 months postoperatively. Between 1 and 6 months, there was a mean hyperopic shift of 0.20 D. There was clinically significant epithelial ingrowth into the interface in two eyes. CONCLUSION Hyperopic lamellar keratoplasty is an effective method of reducing Hyperopia and induces little irregular astigmatism. The nomogram we used produces a consistent undercorrection. Refraction appears to stabilize at 1 month, but longer follow up is necessary to assess stability.

Jose F Alfonso - One of the best experts on this subject based on the ideXlab platform.

  • central vault after phakic intraocular lens implantation correlation with anterior chamber depth white to white distance spherical equivalent and patient age
    Journal of Cataract and Refractive Surgery, 2012
    Co-Authors: Jose F Alfonso, Luis Fernandezvega, Carlos Lisa, Paulo Rodrigues Fernandes, Jorge Jorge, Robert Montes Mico
    Abstract:

    Purpose To compare the central postoperative vault of a phakic intraocular lens (pIOL) to correct myopia, myopic astigmatism, and Hyperopia and identify ocular and lens parameters that might predict the vault amount. Setting Fernandez-Vega Ophthalmological Institute, Oviedo, Spain. Design Cohort study. Methods Three months after implantation of Implantable Collamer Lens pIOLs to correct myopia, Hyperopia, and myopic astigmatism, central vault was measured using optical coherence tomography. Patients were divided into groups according to the preoperative anterior chamber depth (ACD) to compare the effects of ACD, white-to-white (WTW) distance, and lens diameter on postoperative pIOL vault. Results Hyperopic pIOLs had statistically significantly lower vault followed by myopic pIOLs and toric pIOLs, which had a higher mean value and narrower range (260 to 860 μm). Measured vaults had a positive correlation with preoperative ACD (r = .32, P Conclusions Central vaulting was lower in hyperopic eyes. Current nomograms for pIOL diameter selection based on ACD and WTW might yield ideal vault and may have to be adjusted for older patients, shallower ACD, lower WTW, and lower SE. Financial Disclosure No author has a financial or proprietary interest in any material or method mentioned.

  • central vault after phakic intraocular lens implantation correlation with anterior chamber depth white to white distance spherical equivalent and patient age
    Journal of Cataract and Refractive Surgery, 2012
    Co-Authors: Jose F Alfonso, Luis Fernandezvega, Carlos Lisa, Paulo Rodrigues Fernandes, Jorge Jorge, Robert Montes Mico
    Abstract:

    Purpose To compare the central postoperative vault of a phakic intraocular lens (pIOL) to correct myopia, myopic astigmatism, and Hyperopia and identify ocular and lens parameters that might predict the vault amount. Setting Fernandez-Vega Ophthalmological Institute, Oviedo, Spain. Design Cohort study. Methods Three months after implantation of Implantable Collamer Lens pIOLs to correct myopia, Hyperopia, and myopic astigmatism, central vault was measured using optical coherence tomography. Patients were divided into groups according to the preoperative anterior chamber depth (ACD) to compare the effects of ACD, white-to-white (WTW) distance, and lens diameter on postoperative pIOL vault. Results Hyperopic pIOLs had statistically significantly lower vault followed by myopic pIOLs and toric pIOLs, which had a higher mean value and narrower range (260 to 860 μm). Measured vaults had a positive correlation with preoperative ACD ( r = .32, P r = .29, P r = −0.21, P r = −0.12, P =.025). Eyes with a vault of 250 μm or less had a shallower ACD than eyes with a vault between 250 μm and 750 μm (mean difference −0.11 mm; P =.012) and those with a vault greater than 750 μm (mean difference −0.25 mm; P Conclusions Central vaulting was lower in hyperopic eyes. Current nomograms for pIOL diameter selection based on ACD and WTW might yield ideal vault and may have to be adjusted for older patients, shallower ACD, lower WTW, and lower SE. Financial Disclosure No author has a financial or proprietary interest in any material or method mentioned.

James J Salz - One of the best experts on this subject based on the ideXlab platform.

  • lasik correction of spherical Hyperopia hyperopic astigmatism and mixed astigmatism with the ladarvision excimer laser system
    Ophthalmology, 2002
    Co-Authors: James J Salz, Christy Stevens
    Abstract:

    Abstract Objective To assess the safety and effectiveness of the LADARVision active tracking narrow beam excimer laser system (Alcon Surgical, Orlando, FL) using laser in situ keratomileusis (LASIK) for correction of spherical Hyperopia, hyperopic astigmatism, and mixed astigmatism. Design A multicenter, prospective non-randomized (self-controlled) comparative trial. Participants A total of 360 eyes, including 152 spherical hyperopic, 143 hyperopic astigmatic, and 65 mixed astigmatic, were treated for up to +6.00-diopter (D) sphere with up to −6.00-D cylinder. Intervention Treatments were performed at six sites in the United States using a 6-mm optic zone with a 1.5-mm peripheral blend zone for a maximum ablation zone diameter of 9 mm. Main outcome measures Uncorrected visual acuity (UCVA), manifest refraction, vector analysis, best spectacle-corrected visual acuity (BSCVA), complications and adverse reactions, subjective symptoms, and patient satisfaction. Results Six and 12 months of follow-up, respectively, were available on 143 and 117 spherical hyperopic eyes, 124 and 74 hyperopic astigmatic eyes, and 57 and 38 mixed astigmatic eyes, respectively. For spherical hyperopes at 6 and 12 months, UCVA was 20/40 or better in 93.4% and 93.9% of eyes, respectively. The manifest refraction spherical equivalent (MRSE) was within 0.50 D of intended in 65.0% and 74.1% of eyes, respectively, and within 1.00 D in 87.4% and 91.4%, respectively. Refractive stability was demonstrated in 94.2% or more of eyes between the intervals of 1 to 3 months and 3 to 6 months and in 95.3% or more of eyes to 12 months. A loss of two lines of BSCVA occurred in 3.5% and 3.4%, respectively, and no eyes lost more than two lines. For hyperopic astigmats at 6 and 12 months, UCVA was 20/40 or better in 90.9% and 93.8% of eyes, respectively. The MRSE was within 0.50 D of intended in 60.5% and 73.0% of eyes, respectively, and within 1.00 D in 88.7% and 89.2% of eyes, respectively. Refractive stability was demonstrated in 96.5% or more of eyes, respectively, between the intervals of 1 to 3 months and 3 to 6 months and 95.5% or more to 12 months. A loss of two lines of BSCVA occurred in 5.8% and 1.4% of eyes, respectively, and no eyes lost more than two lines. For mixed astigmats at 6 and 12 months, UCVA was 20/40 or better in 92.6% and 94.4% of eyes, respectively. The MRSE was within 0.50 D of intended in 64.9% and 73.7% of eyes, respectively, and within 1.00 D in 87.7% and 94.7% of eyes, respectively. Refractive stability was demonstrated in 100% of eyes between the intervals of 1 to 3 months and 3 to 6 months and in 97.0% or more to 12 months. A loss of two lines of BSCVA occurred in 1.9% and 0.0% of eyes, respectively, and no eyes lost more than two lines. Conclusions The data support safety and effectiveness of the LASIK correction of spherical Hyperopia, hyperopic astigmatism, and mixed astigmatism with the LADARVision system.

  • lasik correction of spherical Hyperopia hyperopic astigmatism and mixed astigmatism with the ladarvision excimer laser system
    Ophthalmology, 2002
    Co-Authors: James J Salz, Christy Stevens
    Abstract:

    Abstract Objective To assess the safety and effectiveness of the LADARVision active tracking narrow beam excimer laser system (Alcon Surgical, Orlando, FL) using laser in situ keratomileusis (LASIK) for correction of spherical Hyperopia, hyperopic astigmatism, and mixed astigmatism. Design A multicenter, prospective non-randomized (self-controlled) comparative trial. Participants A total of 360 eyes, including 152 spherical hyperopic, 143 hyperopic astigmatic, and 65 mixed astigmatic, were treated for up to +6.00-diopter (D) sphere with up to −6.00-D cylinder. Intervention Treatments were performed at six sites in the United States using a 6-mm optic zone with a 1.5-mm peripheral blend zone for a maximum ablation zone diameter of 9 mm. Main outcome measures Uncorrected visual acuity (UCVA), manifest refraction, vector analysis, best spectacle-corrected visual acuity (BSCVA), complications and adverse reactions, subjective symptoms, and patient satisfaction. Results Six and 12 months of follow-up, respectively, were available on 143 and 117 spherical hyperopic eyes, 124 and 74 hyperopic astigmatic eyes, and 57 and 38 mixed astigmatic eyes, respectively. For spherical hyperopes at 6 and 12 months, UCVA was 20/40 or better in 93.4% and 93.9% of eyes, respectively. The manifest refraction spherical equivalent (MRSE) was within 0.50 D of intended in 65.0% and 74.1% of eyes, respectively, and within 1.00 D in 87.4% and 91.4%, respectively. Refractive stability was demonstrated in 94.2% or more of eyes between the intervals of 1 to 3 months and 3 to 6 months and in 95.3% or more of eyes to 12 months. A loss of two lines of BSCVA occurred in 3.5% and 3.4%, respectively, and no eyes lost more than two lines. For hyperopic astigmats at 6 and 12 months, UCVA was 20/40 or better in 90.9% and 93.8% of eyes, respectively. The MRSE was within 0.50 D of intended in 60.5% and 73.0% of eyes, respectively, and within 1.00 D in 88.7% and 89.2% of eyes, respectively. Refractive stability was demonstrated in 96.5% or more of eyes, respectively, between the intervals of 1 to 3 months and 3 to 6 months and 95.5% or more to 12 months. A loss of two lines of BSCVA occurred in 5.8% and 1.4% of eyes, respectively, and no eyes lost more than two lines. For mixed astigmats at 6 and 12 months, UCVA was 20/40 or better in 92.6% and 94.4% of eyes, respectively. The MRSE was within 0.50 D of intended in 64.9% and 73.7% of eyes, respectively, and within 1.00 D in 87.7% and 94.7% of eyes, respectively. Refractive stability was demonstrated in 100% of eyes between the intervals of 1 to 3 months and 3 to 6 months and in 97.0% or more to 12 months. A loss of two lines of BSCVA occurred in 1.9% and 0.0% of eyes, respectively, and no eyes lost more than two lines. Conclusions The data support safety and effectiveness of the LASIK correction of spherical Hyperopia, hyperopic astigmatism, and mixed astigmatism with the LADARVision system.